CIK 0001834105 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
IMPACT BIOMEDICAL INC.
Sign in to watch- Ticker
- IBO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 853926944
- Phone
- 585 232 1500
- Business address
- 275 WIREGRASS PKWY,, WEST HENRIETTA, NY, 14586
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,686
- in 1 filing
Net −$1,686. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-05 | Heuszel Frank D Chief Executive Officer | Purchase | +500 | $2.26 | $1K | 97,344 |
| 2024-12-02 | DSS, INC. 10% owner | Sale | −20 | $2.90 | $58 | 53,080 |
| 2024-11-27 | Heuszel Frank D Chief Executive Officer | Purchase | +500 | $2.61 | $1K | 96,844 |
| 2024-11-26 | Heuszel Frank D Chief Executive Officer | Purchase | +550 | $2.63 | $1K | 95,844 |
| 2024-11-26 | Heuszel Frank D Chief Executive Officer | Purchase | +500 | $2.59 | $1K | 96,344 |
| 2024-11-18 | DSS, INC. 10% owner | Sale | −5,000 | $3.02 | $15K | 53,100 |
| 2024-11-13 | DSS, INC. 10% owner | Sale | −200 | $2.80 | $560 | 58,100 |
| 2024-11-12 | DSS, INC. 10% owner | Sale | −500 | $2.76 | $1K | 58,300 |
| 2024-09-18 | DSS, INC. 10% owner | Purchase | +1,000 | $2.33 | $2K | 58,800 |
| 2024-09-17 | DSS, INC. 10% owner | Purchase | +7,800 | $2.40 | $19K | 57,800 |
| 2024-09-16 | DSS, INC. 10% owner | Purchase | +50,000 | $2.69 | $135K | 50,000 |
Page 3 of 3 · 51 trades